ECOVITA Study. Observational Study on Sars-COV 2 Population Hospitalized in the Italian Country
试验速览
- 阶段
- 不适用
- 入组人数
- 950
- 试验地点
- 1
- 主要终点
- validation of lung ultrasound score
研究概览
简要总结
Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed analyzing chest posterior and lateral spaces, considering the number of artefacts generated by the inflammed interstitium (B lines), the characteristics of the pleural line and the presence or not of consolidation areas.
The comparison between LUS and chest tomography (CT), the current gold standard for the diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the reliability of such technique. Hence, the validation on a really large sample size of the ultrasound tool performed by dedicated personnel with high expertise, may allow the validation both in the clinical practice and in emergency and ordinary wards.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •men and women;
- •confirmed COVID19 diagnosis after nasal-oropharyngeal swab;
- •any symptom at hospitalization
- •any therapy
- •any pre-existing comorbidity
排除标准
- •pregnant women
- •healthy subjects with other respiratory diseases different from COVID-19
结局指标
主要结局
validation of lung ultrasound score
时间窗: 6 months
validation of lung ultrasound in the clinical practice of diagnosis of complications of low respiratory tracts during COVID-19
次要结局
- Association of LUS score with clinical outcome(6 months)
- Association of LUS score with duration of hospitalization (days)(6 months)
- Association of LUS score with respiratory support required(6 months)
研究者
Luca Rinaldi
Researcher
University of Campania "Luigi Vanvitelli"